---
title: "Duty-Free Expansion and Retail Resilience Highlight Hong Kong's Sector Divergence"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/302392002.md"
description: "China Tourism Group Duty Free secured Beijing Capital Airport's T3 terminal contract while Chow Sang Sang reported 7% same-store sales growth in Hong Kong/Macao. JD Health's revenue rose 24.5% YoY, contrasting with Sunac's 21.4 billion yuan enforcement actions. Sector divergence intensifies as niche players navigate mixed fundamentals."
datetime: "2026-10-20T09:17:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/302392002.md)
  - [en](https://longbridge.com/en/news/302392002.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/302392002.md)
generator: "portal-rs"
---

# Duty-Free Expansion and Retail Resilience Highlight Hong Kong's Sector Divergence

Hong Kong's lesser-followed equities are revealing stark contrasts between resilient consumer plays and pressured legacy sectors. China Tourism Group Duty Free (1880.HK) clinched the Beijing Capital Airport T3 terminal concession with 10,646 square meters of retail space, signaling renewed momentum in travel retail after pandemic setbacks. The company's Sanya Taikoo Li project is opening in phases, complementing its 4A-rated duty-free complex.

Jewelry retailer Chow Sang Sang (0116.HK) posted 3% year-on-year retail sales growth in Q3 2026, with mainland China same-store sales up 4% and Hong Kong/Macao rising 7%. CICC maintains its Outperform rating, citing a 37% upside to its HKD 18.51 target price. Meanwhile, China Foods (0506.HK), a key Coca-Cola bottler, achieved 8.3% revenue growth despite muted trading activity.

In healthcare, JD Health (6618.HK) reported CNY 17.65 billion in Q2 2025 revenue, a 24.5% YoY increase, with analysts spotlighting its AI tool integration. Fosun Pharma (2196.HK) advanced its oncology pipeline as Breyanzi's regulatory application gained NMPA acceptance, while pursuing Green Valley Pharma's 51% stake to enter Alzheimer's treatment.

Challenges persist elsewhere. Sunac China (1918.HK) faced six new enforcement actions totaling CNY 2.14 billion in mid-October, underscoring post-restructuring pressures. Transwarp (6727.HK) saw its H-shares trade at 67% discount to A-shares following Tencent's stake reduction, though technical rebound emerged recently. Leftfield Printing (1540.HK) surged 19.59% weekly while Glorious Sun Enterprises (0393.HK) attracted chairman's continuous buying, reflecting selective investor interest in turnaround stories.

### Related Stocks

- [06618.HK](https://longbridge.com/en/quote/06618.HK.md)
- [06727.HK](https://longbridge.com/en/quote/06727.HK.md)
- [00116.HK](https://longbridge.com/en/quote/00116.HK.md)
- [00393.HK](https://longbridge.com/en/quote/00393.HK.md)
- [01540.HK](https://longbridge.com/en/quote/01540.HK.md)
- [00506.HK](https://longbridge.com/en/quote/00506.HK.md)
- [01918.HK](https://longbridge.com/en/quote/01918.HK.md)
- [02196.HK](https://longbridge.com/en/quote/02196.HK.md)
- [01880.HK](https://longbridge.com/en/quote/01880.HK.md)
- [02108.HK](https://longbridge.com/en/quote/02108.HK.md)

## Related News & Research

- [China Foods Holdings Delays Quarterly Report as Information Gathering Lags](https://longbridge.com/en/news/305298996.md)
- [Shanghai Fosun Pharmaceutical Files Next-Day HKEX Return Announcing Share Buyback](https://longbridge.com/en/news/305444728.md)
- [China Foods Signs Three-Year Concentrate Purchase Agreement With Coca-Cola Shanghai](https://longbridge.com/en/news/305012600.md)
- [Fosun Pharma Subsidiary Fosun Kairos Starts Phase II Trial of FKC516 for B-Cell Lymphoma](https://longbridge.com/en/news/305300840.md)
- [K2 F&B Leases Singapore Food Centre for Three Years at S$ 2.82 Million](https://longbridge.com/en/news/305147992.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**